Cite
HARVARD Citation
Ho, C. et al. (n.d.). 108PA pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo. Annals of oncology. p. . [Online].